project id: TCGA-LIHC; case submitter id: TCGA-KR-A7K8; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.73; rna integrity number: 7.3; age at index: 57; days to birth: -20914; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1955; age at diagnosis: 20914; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 906.0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8170/3; primary diagnosis: Hepatocellular carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: No; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 435; initial weight: 80.0; oct embedded: false; preservation method: Unknown; sample id: 30f43a40-040f-4c42-a84e-0ba7ec9c8945; sample submitter id: TCGA-KR-A7K8-01A; portion id: 28feac7b-f5ef-4a20-9b46-ca42e51fac15; portion submitter id: TCGA-KR-A7K8-01A-11; slide id: c1708f35-0cce-4ac5-9af1-48682b756b24; slide submitter id: TCGA-KR-A7K8-01A-01-TS1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP;